SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is generating significant momentum following its landmark marketing approval in Japan, which has prompted analysts to raise price targets to $12. Investors are actively discussing the company's strong cash position and the upcoming U.S. clinical trial milestones, framing the stock as a compelling, undervalued opportunity in the oncology sector.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is capturing significant community attention as it secures strategic government contracts and deepens its collaboration with NVIDIA, leading investors to view it as a compelling, undervalued alternative to other quantum stocks. While some express frustration with recent price volatility and de-SPAC pressure, many are actively accumulating shares based on a long-term conviction in the companys debt-free balance sheet and its pivotal role in national security and AI integration.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing heightened volatility and intense trader interest as it joins the S&P 500 index, a move that is triggering mandatory institutional buying and significant market-making activity. The community remains sharply divided, with bulls pointing to the company's critical role in the AI optics supply chain and Nvidia's strategic investment, while bears warn of stretched valuations and risks stemming from shifting industry preferences toward copper technologies.

VanEck ETF Trust - VanEck Agribusiness ETF

VanEck Agribusiness ETF

Investors are increasingly rotating into the agricultural sector, viewing agribusiness as a defensive play that is showing signs of a structural breakout. The community is actively discussing the sector's potential to benefit from fresh inflows and long-term food demand, with many highlighting agribusiness as an undervalued, unloved trade that is finally beginning to gain momentum.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to persistent, high-profile acquisition rumors linking the French biotech to potential suitors like Eli Lilly and AstraZeneca, fueled by reports from investigative outlets and strong institutional interest. The community remains focused on the company's robust ulcerative colitis drug pipeline and the potential for a significant buyout premium, keeping trading volume high as investors monitor for official confirmation of a deal.

Invesco DB Multi-Sector Commodity Trust - Invesco DB Agriculture Fund

Invesco DB Agriculture Fund

The Invesco DB Agriculture Fund is trending as investors weigh persistent global supply chain disruptions and geopolitical instability against the potential for demand destruction in food commodities. Market participants are intensely focused on how persistent inflation, exacerbated by rising fertilizer and energy costs, will continue to impact the agriculture sector's profitability.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is facing significant volatility as investors debate the viability of the company's turnaround plan, balancing recent traffic improvements against margin pressures and intense competition from faster, value-oriented rivals. The community remains deeply divided, with some betting on a long-term recovery under new leadership while others highlight declining brand loyalty and store closures as indicators of structural trouble.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently under pressure as investors weigh recent reports of large-scale layoffs against concerns over massive AI infrastructure spending and looming legal challenges. Community sentiment is sharply divided between long-term believers citing the company's valuation and dominant advertising position, and skeptical traders who view recent price action as a technical breakdown signaling further downside risk.

Global X Funds - Global X Silver Miners ETF

Global X Silver Miners ETF ($SIL) is trending as investors react to a significant silver supply-demand deficit and increasing industrial usage in sectors like AI and electric vehicles. The community is actively debating the sustainability of the recent rally, with many traders focusing on the structural decoupling of physical silver prices from paper-contract markets, while others monitor for signs of a technical correction following the rapid price appreciation.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is gaining significant momentum as investors pivot toward defense-tech and earth-observation stocks, bolstered by its new prime contractor status under the Pentagon's SHIELD program. The community is actively discussing the company's expanding backlog, its strategic AI partnerships with industry giants like NVIDIA and Google, and its growing importance in global national security as a key source of real-time geospatial intelligence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Turn Therapeutics Talks GX-03 Phase II Eczema Data Timeline and Non-Systemic Topical Strategy

Turn Therapeutics (NASDAQ:TTRX) executives outlined the company's focus on inflammatory skin disease and provided updates on its lead topical candidate, GX-03, during a presentation at an...

Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs

Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies for dermatologic conditions, today announced the appointment...

Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences

Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies for dermatology, today announced that Brad Burnam, Chief...

Turn Therapeutics' (TTRX) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital restated a "buy" rating and issued a $8.00 price target on shares of Turn Therapeutics in a report on Tuesday...

Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference

Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunological therapies for dermatologic and infectious diseases, today announced...

Turn Therapeutics (NASDAQ:TTRX) Upgraded to "Strong-Buy" at D Boral Capital

D Boral Capital upgraded shares of Turn Therapeutics to a "strong-buy" rating in a research report on Monday...

Turn Therapeutics (NASDAQ:TTRX) Coverage Initiated at D. Boral Capital

D. Boral Capital assumed coverage on Turn Therapeutics in a research report on Monday. They set a "buy" rating and a $8.00 price target on the stock...

Turn Therapeutics (NASDAQ:TTRX) Director Purchases $33,945.92 in Stock

Turn Therapeutics Inc. (NASDAQ:TTRX - Get Free Report) Director Arthur Golden bought 9,868 shares of Turn Therapeutics stock in a transaction that occurred on Monday, November 24th. The stock was...

Insider Buying: Turn Therapeutics (NASDAQ:TTRX) Director Buys 20,532 Shares of Stock

Turn Therapeutics Inc. (NASDAQ:TTRX - Get Free Report) Director Arthur Golden acquired 20,532 shares of Turn Therapeutics stock in a transaction dated Friday, November 21st. The shares were bought at...

Turn Therapeutics (NASDAQ:TTRX) Releases Quarterly Earnings Results

Turn Therapeutics (NASDAQ:TTRX - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.07) EPS for the quarter...

Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. Its primary development programs focus on dermatological diseases. The company was founded on January 6, 2015 and is headquartered in Westlake Village, CA.

Current Price	$3.44
Prev Close	$3.43
Open	$3.35
Dividend Yield	N/A
50-Day Moving Average	$3.92
Beta	1.44
Avg. Volume	20,210.85
PE Ratio	-25.98

52-Week High	$26.50
52-Week Low	$2.57
Market Capitalization	$101.29M
EPS (Annual)	-$0.1318
Price to Book	173.13
Revenue Per Employee	N/A

TTRX
Turn Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TTRX News

TTRXTurn Therapeutics Inc